HON vs UNH: Which Is the Better Buy?
Side-by-side comparison of Honeywell International Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Honeywell International Inc. · Industrials
$212.55
-8.5% upside to fair value
Med Conviction
Grade C
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
HON |
UNH |
| Current Price |
$212.55 |
$375.21 |
| Fair Value Estimate |
$194.50 |
$481.06 |
| Upside to Fair Value |
-8.5%
|
+28.2%
|
| Market Cap |
$67.4B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
7.4x
|
15.0x
|
| Price / Sales |
1.9x
|
0.8x
|
| Price / FCF |
16.4x
|
14.4x
|
| Revenue Growth YoY |
-6.1%
|
+0.4%
|
| Gross Margin |
36.6%
|
22.5%
|
| Operating Margin |
14.1%
|
4.8%
|
| Return on Equity |
41.7%
|
14.6%
|
| Dividend Yield |
2.09% |
2.41% |
| FCF Yield |
6.11%
|
6.95%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Honeywell International Inc. is a 101,000-employee diversified industrial technology and manufacturing conglomerate, led by CEO Vimal Kapur, spanning Aerospace, Building Technologies, Performance Materials and Technologies, and Safety and Productivity Solutions. Business quality is solid but not exceptional: the company carries a durable intangible-asset and switching-cost moat in aerospace avion…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
HON |
UNH |
| Zone Low |
$145.88 |
$360.80 |
| Zone High |
$165.32 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|